Drug-free depression options on an employer plan in St. Louis

You have an employer health plan, a desk job in Clayton or a shift at a plant in north county, and a depression that has shrugged off every pill your doctor has tried. You are tired of side effects and tired of waiting to see if the next one works. What you want is an option that is not another medication. In St. Louis, those options exist, and your plan may pay for more of them than you think. This guide is about finding them.

You are not the only one who wants this

This summer our publisher funded a questionnaire that 443 adults completed, spread over ten Midwest states with Missouri and Illinois among them. It asked whether a drug-free depression option mattered to people and whether they knew about TMS, transcranial magnetic stimulation, one of the main drug-free treatments.

Nearly two-thirds, 64 percent, said drug-free mattered to them. A quarter, 25 percent, were familiar with TMS. The biggest group, just over half of the sample, cared about avoiding medication yet had never heard of the treatment built for exactly that.

All of these come from the final validated data for the whole sample. Commercial coverage was the most common kind, reported by 39 percent of respondents in a question where people could pick more than one plan, and those 173 people on commercial plans valued drug-free care more, at 71 percent.

The drug-free options, in plain terms

• TMS. Pulses from a magnetic coil on the scalp reach mood-related brain regions. The FDA cleared it, the device equivalent of approval, for adults whose major depression has not lifted enough with antidepressants. No anesthesia is used, you stay awake, and driving yourself is usually fine. Sessions run most weekdays for several weeks.
• Evidence-based psychotherapy. Structured talk therapy, cognitive behavioral therapy being one example, have solid evidence for depression and are widely covered.
• ECT. Electroconvulsive therapy is drug-free in the sense that it is not a daily medication, but it requires brief general anesthesia. It is usually reserved for severe or highly resistant depression.

For contrast, Spravato, the brand of esketamine, counts as a medication; the FDA approved that nasal spray for depression that resists standard treatment, and each dose is supervised in a certified clinic. It may suit some people, but not anyone whose aim is to avoid drugs. Brain Recovery Centers describes what Spravato treatment involves for those weighing it.

None of these works for everyone, and whether any fits you is a clinician's call. Many people continue their antidepressant during TMS or therapy, and changes to medication should only happen with your prescriber.

Step 1: Read your plan's rules before you shop

Most commercial insurers publish a medical policy for TMS. Search your insurer's website for "transcranial magnetic stimulation medical policy," or call member services and ask them to email it. Look for:

• Whether prior authorization is required (it usually is)
• How many antidepressant trials you must have documented
• Whether a trial of psychotherapy is also required
• Session limits and rules for a repeat course
• Your deductible and coinsurance for outpatient behavioral health

At a big employer, check with HR on whether the plan is self-funded, since such plans can set their own rules.

Step 2: Check the network on both sides of the river

The St. Louis area spans two states. Some employer plans treat Missouri and Illinois providers the same, some do not. If you live in St. Charles County and work in the Metro East, or the reverse, confirm that a TMS practice or therapist is in network for your specific plan before your first visit.

Your insurer's online directory, filtered for psychiatry and TMS, is the most reliable way to see which ones are in network.

Step 3: Weigh the commute seriously

TMS is not a once-a-month appointment. A standard course means showing up on most weekdays for weeks. A practice twenty minutes from your office can be sustainable. One an hour away through I-64 traffic may not be.

People already weight proximity heavily. Proximity to home ranked top-two for 43 percent of survey respondents, trailing only insurance at 85 percent. For a daily treatment, proximity matters even more.

Ask practices about early-morning or lunchtime slots. Need time off? Eligible workers may be able to take intermittent, job-protected leave for their own serious health condition under the federal Family and Medical Leave Act. HR can tell you whether you qualify.

Step 4: Go through your doctor

You can call a TMS practice directly, but a referral from your own doctor often smooths prior authorization, and the survey suggests it is also the voice people trust. A go-ahead from their doctor was what 74 percent of respondents needed to try something new, while online searching was the starting point for only 12 percent.

Bring a written record of each antidepressant: name, dose, duration, and the reason it ended. That document is what your insurer will want to see.

Step 5: Ask the practice the right questions

• Are you in network with my plan, and do you submit the prior authorization?
• How much would a full course cost me after insurance?
• Which device do you treat with, and what has the FDA cleared it for?
• Who assesses me first, and who supervises the sessions?
• What happens if the first course does not help?

That third question matters. FDA status carried serious weight in the survey, too: 59 percent called it decisive or major.

If you are denied

Ask for the reason in writing. Missing documentation is a common culprit. Your provider may be able to resubmit or ask the insurer's doctor for a direct review call, and an appeal is your right. Just over half of survey respondents said they would rather work through insurance hoops than pay out of pocket, so persistence is well within the norm.

Nothing in this guide is medical advice.

If the weight of depression has you thinking about suicide, set the logistics aside for now and talk to someone. Dial or text 988, day or night, to reach the Suicide and Crisis Lifeline. A trained counselor will answer.

Methodology

Our publisher arranged and paid for this survey, and Pollfish fielded it on its consumer panel, and the last response arrived June 23, 2026. The sample: n=443 adults, 18 to 64, from Missouri, Illinois, Iowa, Kansas, Oklahoma, Nebraska, Wisconsin, Minnesota, Indiana, and Ohio. Other than the commercial plan figure, results describe everyone, and each figure is final now that the panel's validation is signed off.